Dong-Liang Chen Selected Research

Dong-Liang Chen Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 04/2013
13	Stomach Neoplasms (Stomach Cancer) 07/2023 - 01/2016
12	Neoplasm Metastasis (Metastasis) 07/2023 - 04/2013
11	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 02/2013
3	Esophageal Squamous Cell Carcinoma 01/2022 - 10/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024
1	Signet Ring Cell Carcinoma 01/2023
1	Disseminated Intravascular Coagulation 01/2023
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Glioma (Gliomas) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Allergic Contact Dermatitis 08/2019
1	Hypersensitivity (Allergy) 08/2019
1	Hypoxia (Hypoxemia) 06/2019
1	Carcinogenesis 01/2018
1	Starvation 01/2018
1	Cardiotoxicity 09/2017
1	Breast Neoplasms (Breast Cancer) 09/2017
1	Pain (Aches) 10/2016
1	Vomiting 10/2016
1	Constipation 10/2016
1	Cancer Pain 10/2016
1	Nausea 10/2016
1	Rheumatoid Arthritis 01/2015
1	Colonic Neoplasms (Colon Cancer) 12/2014
1	Rectal Neoplasms (Rectal Cancer) 12/2014
1	Adenocarcinoma 01/2014
1	Hepatitis B 07/2012
1	Virus Diseases (Viral Diseases) 07/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2012

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 07/2023 - 02/2013
7	Long Noncoding RNAIBA 01/2022 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2014
5	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2019
4	Circular RNAIBA 01/2024 - 12/2021
4	MicroRNAs (MicroRNA)IBA 01/2023 - 08/2014
3	Messenger RNA (mRNA)IBA 07/2023 - 04/2013
3	NADP (NADPH)IBA 07/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
1	lorlatinibIBA 05/2024
1	Anaplastic Lymphoma KinaseIBA 05/2024
1	brigatinibIBA 05/2024
1	Dacarbazine (DIC)FDA LinkGeneric 01/2023
1	LigandsIBA 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Histones (Histone)IBA 01/2022
1	Small Nuclear Ribonucleoproteins (snRNP)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	3,3,5,5-tetramethyl-1-pyrroline N-oxide (TMPO)IBA 01/2022
1	Circulating Tumor DNAIBA 10/2020
1	NickelIBA 08/2019
1	MetalsIBA 08/2019
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	ORALIT (ORS)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	B7-H1 AntigenIBA 01/2018
1	EnzymesIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	pirarubicinIBA 09/2017
1	Epirubicin (Ellence)FDA LinkGeneric 09/2017
1	AnthracyclinesIBA 09/2017
1	Competitive Endogenous RNAIBA 01/2017
1	Leucovorin (Folinic Acid)FDA Link 01/2017
1	MelatoninIBA 10/2016
1	Fluorouracil (Carac)FDA LinkGeneric 10/2016
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2016
1	Opioid Analgesics (Opioids)IBA 10/2016
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2016
1	Morphine (MS Contin)FDA LinkGeneric 10/2016
1	phenethyl isothiocyanate (PEITC)IBA 01/2016
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2015
1	Bevacizumab (Avastin)FDA Link 12/2015
1	CytokinesIBA 12/2015
1	Phosphatidylethanolamine Binding ProteinIBA 10/2015
1	shikoninIBA 01/2015
1	ParaffinIBA 12/2014
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 08/2014
1	PlatinumIBA 01/2014
1	Carcinoembryonic AntigenIBA 01/2014
1	PaxillinIBA 04/2013
1	Indicators and Reagents (Reagents)IBA 04/2013
1	Hepatitis B e AntigensIBA 07/2012
1	ABO Blood-Group SystemIBA 07/2012
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2012

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 05/2024 - 01/2014
3	Therapeutics 01/2023 - 12/2015
3	Immunotherapy 01/2023 - 10/2020
1	Glycemic Control 04/2022
1	Synchrotrons 08/2019
1	Adjuvant Chemotherapy 01/2014
1	Gastrectomy 01/2014